MedPath

Mandala Art Therapy on attention level among Attention Deficit Hyperactivity Disorder children

Not yet recruiting
Conditions
Attention-deficit hyperactivity disorder, predominantly inattentive type,
Registration Number
CTRI/2025/06/088556
Lead Sponsor
S Shilpa
Brief Summary

This is a randomized controlled trial to assess the effectiveness of Mandala Art Therapy on attention level among attention deficit hyperactivity disorder children attending Early Intervention Centre in a tertiary care hospital in Western Maharashtra. 22 children with attention deficit hyperactivity disorder will be given Mandala Art Therapy for 06 weeks duration, 03 sessions per week for 30 minutes and 22 children will receive the routine treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
44
Inclusion Criteria
  • Children aged 6- 12 years diagnosed with Attention Deficit Hyperactivity Disorder.
  • Children with no visual or motor impairments that might interfere with participation in Mandala Art Therapy.
Exclusion Criteria
  • Children with severe intellectual disabilities, that might interfere with participation.
  • Children with acute psychiatric conditions like severe anxiety and depression requiring immediate medical attention.
  • Children with any physical disabilities affecting their ability to engage in art therapy activities.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in attention levelpre intervention score of attention | post intervention score of attention after 01 week of completion of intervention
Secondary Outcome Measures
NameTimeMethod
NANA

Trial Locations

Locations (1)

COMMAND HOSPITAL

🇮🇳

Pune, MAHARASHTRA, India

COMMAND HOSPITAL
🇮🇳Pune, MAHARASHTRA, India
S Shilpa
Principal investigator
7459058853
shilpasubramanian2@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.